检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]第四军医大学口腔医院麻醉科,陕西西安710032
出 处:《口腔颌面外科杂志》2006年第4期356-358,共3页Journal of Oral and Maxillofacial Surgery
摘 要:目的:观察不同配方镇痛药用于颌面外科手术后病人自控静脉镇痛(patient controlled intravenous analgesia,PCIA)的效果。方法:颌面外科全麻手术患者共296例,术后接受PCIA治疗,按术后镇痛药配方不同分成8组,分别是:芬太尼组(F)、芬太尼-氟哌利多组(FD)、芬太尼-昂丹司琼组(FO)、舒芬太尼组(SF)、舒芬太尼-昂丹司琼组(SFO)、丁丙诺非组(B)、丁丙诺非-昂丹司琼组(BO)和氯诺昔康组(L)。所用药物均加生理盐水至100 mL,按2 mL/h,单次剂量0.5 mL,锁定时间15 min。分别进行视觉模拟评分(visual analogue scale,VAS)、患者满意度和不良反应的比较。结果:SFO和L组的VAS各是1.3±0.7和1.3±0.6,与F组和FD组比较差异显著(P<0.05);SFO、SF和L组的患者满意率高于FD组;各组间不良反应发生率无明显差异,恶心呕吐发生率以口内手术病例为高。结论:芬太尼、舒芬太尼、丁丙诺非和氯诺西康用于颌面外科手术后PCIA中均有效。Objective: To assess the analgesia effect of patient controlled intravenous analgesia (PCIA) with different analgetics. Methods:296 patients underwent oral and maxillofacial operation and PCIA treatment postoperation,were divided into 8 groups according the medicine of PCIA. Group F were treated with fentanyl, group FD were treated with fentanyl+droperidol, group FO were treated with fentanyl+ondroperidol, group SF were treated with sufentanil, group SFO were treated with sufentanil+ondroperidol, group B were treated with buprenorphine, group BO were treated with buprenorphine+ondroperidol, and group L were treated with lornoxicam.The drugs used in all groups were diluted in 100mL saline seperately,background dose of 2mL/h,bolus 0.5mL,and lockout time was 15 min.The severity of pain,incidence of nausea and vomiting,and patient's satisfaction were analyzed statistically. Results: There was no significant difference in side-effecets among 8 groups. The incidence of nausea and vomiting was higher in intraoral operation than extraoral operation. Conclusion: The study suggests that fentanyl, sufentanil, buprenorphine and lornoxicam are effective in PCIA for oral and maxillofacial operation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15